These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 21693112

  • 1. Gastric cancer - The role of matrix metalloproteinases in tumor progression.
    Lukaszewicz-Zając M, Mroczko B, Szmitkowski M.
    Clin Chim Acta; 2011 Sep 18; 412(19-20):1725-30. PubMed ID: 21693112
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM, Foidart JM, Noel A, Cataldo DD.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):133-44. PubMed ID: 16487964
    [Abstract] [Full Text] [Related]

  • 4. Biological activity and clinical implications of the matrix metalloproteinases.
    Rydlova M, Holubec L, Ludvikova M, Kalfert D, Franekova J, Povysil C, Ludvikova M.
    Anticancer Res; 2008 Mar 08; 28(2B):1389-97. PubMed ID: 18505085
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinases and bladder cancer.
    Kanayama H.
    J Med Invest; 2001 Feb 08; 48(1-2):31-43. PubMed ID: 11286015
    [Abstract] [Full Text] [Related]

  • 6. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
    Groblewska M, Siewko M, Mroczko B, Szmitkowski M.
    Folia Histochem Cytobiol; 2012 Apr 24; 50(1):12-9. PubMed ID: 22532131
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic patterns of metalloproteinases and their tissular inhibitors - clinicopathologic and prognostic significance in colorectal cancer.
    Surlin V, Ioana M, Pleşea IE.
    Rom J Morphol Embryol; 2011 Apr 24; 52(1 Suppl):231-6. PubMed ID: 21424059
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract].
    Piura B, Rabinovich A, Huleihel M.
    Harefuah; 2003 Nov 24; 142(11):786-91, 804. PubMed ID: 14631913
    [Abstract] [Full Text] [Related]

  • 12. [The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis].
    Iwata H, Kobayashi S, Iwase H, Okada Y.
    Nihon Rinsho; 1995 Jul 24; 53(7):1805-10. PubMed ID: 7630023
    [Abstract] [Full Text] [Related]

  • 13. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J.
    Postepy Biochem; 2012 Jul 24; 58(3):353-62. PubMed ID: 23373420
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
    Hirano H, Tsuji M, Kizaki T, Sashikata T, Yoshi Y, Okada Y, Mori H.
    Med Electron Microsc; 2002 Mar 24; 35(1):16-23. PubMed ID: 12111403
    [Abstract] [Full Text] [Related]

  • 15. Complex roles of tissue inhibitors of metalloproteinases in cancer.
    Jiang Y, Goldberg ID, Shi YE.
    Oncogene; 2002 Mar 28; 21(14):2245-52. PubMed ID: 11948407
    [Abstract] [Full Text] [Related]

  • 16. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
    Adithi M, Nalini V, Kandalam M, Krishnakumar S.
    J Pediatr Hematol Oncol; 2007 Jun 28; 29(6):399-405. PubMed ID: 17551402
    [Abstract] [Full Text] [Related]

  • 17. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.
    Gialeli C, Theocharis AD, Karamanos NK.
    FEBS J; 2011 Jan 28; 278(1):16-27. PubMed ID: 21087457
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinases and the thyroid.
    Kraiem Z, Korem S.
    Thyroid; 2000 Dec 28; 10(12):1061-9. PubMed ID: 11201850
    [Abstract] [Full Text] [Related]

  • 19. [Extracellular matrix degradation enzymes: important factors in liver metastasis of colorectal cancer and good targets for anticancer metastatic therapy].
    Ichikawa Y, Ishikawa T, Tanaka K, Togo S, Shimada H.
    Nihon Geka Gakkai Zasshi; 2001 May 28; 102(5):376-80. PubMed ID: 11393999
    [Abstract] [Full Text] [Related]

  • 20. [Matrix metalloproteinases and colorectal cancer].
    Roeb E, Matern S.
    Med Klin (Munich); 2003 Dec 15; 98(12):763-70. PubMed ID: 14685678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.